Display options
Share it on

J Thorac Dis. 2018 Nov;10:S3799-S3808. doi: 10.21037/jtd.2018.09.144.

A review and analysis of strategies for prediction, prevention and management of post-operative atrial fibrillation after non-cardiac thoracic surgery.

Journal of thoracic disease

Heather Smith, Ching Yeung, Stephen Gowing, Mouhannad Sadek, Donna Maziak, Sebastien Gilbert, Farid Shamji, Patrick Villeneuve, Sudhir Sundaresan, Andrew Seely

Affiliations

  1. Division of General Surgery, The Ottawa Hospital, University of Ottawa, Ottawa, ON, Canada.
  2. Division of Thoracic Surgery, The Ottawa Hospital, University of Ottawa, Ottawa, ON, Canada.
  3. Division of Cardiology, The Ottawa Hospital, University of Ottawa, Ottawa, ON, Canada.

PMID: 30505567 PMCID: PMC6258651 DOI: 10.21037/jtd.2018.09.144

Abstract

Atrial fibrillation (AF) is the most common sustained arrhythmia after non-cardiac thoracic surgery and is associated with a significant increase in perioperative morbidity, intensive care unit (ICU) admission, and mortality. Practical guidance is needed to assist clinicians in managing this critical issue and direct further research. Here we aim to provide a synoptic review and analysis of the literature to distil practical recommendations for prediction, prevention and management of post-operative atrial fibrillation (POAF) suitable for clinical application and further evaluation. To predict POAF, risk factors including age, gender, elevated pre-operative heart rate and extent of surgical resection have been reproducibly identified and integrated into scoring systems. To prevent POAF, prophylactic therapy with beta-blockers, amiodarone, or magnesium have demonstrated to be effective, but need further trials in high-risk populations. To manage unstable POAF that precipitates hypotension and hypoperfusion, although rare, requires immediate electrocardioversion to restore cardiac output and adequate oxygen delivery. For hemodynamically stable patients, rate control and prevention of adverse events are the objectives. We propose an individualized approach aimed at rate control using initial incremental low dose beta-blocker or calcium channel blocker (CCB) therapy with close monitoring of a patient's response, and continuation of the drug that they respond to, along with simultaneous identification and reduction of triggers of AF, in order for spontaneous return to sinus rhythm. For patients who persistently fail to respond to rate control therapy, rhythm control may be considered using an agent selected based on the patient's comorbidities and the medications' side effect profile. While controversial and requiring further study, anticoagulation therapy is recommended in patients with risk factors for thromboembolic events after 48 hours of persistent AF. We recommend continuous prospective monitoring of incidence and severity of POAF to track the impact of protocols to predict, prevent and manage POAF.

Keywords: Post-operative atrial fibrillation (POAF); management; prediction; prevention; thoracic surgery

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

References

  1. J Thorac Cardiovasc Surg. 2014 Sep;148(3):e153-93 - PubMed
  2. Ann Thorac Surg. 2010 Aug;90(2):368-74 - PubMed
  3. Europace. 2012 Oct;14(10):1385-413 - PubMed
  4. Am J Cardiol. 1998 Oct 16;82(8A):2N-9N - PubMed
  5. Eur J Cardiothorac Surg. 2001 Oct;20(4):688-93 - PubMed
  6. Ann Thorac Surg. 2005 May;79(5):1698-703 - PubMed
  7. Eur J Cardiothorac Surg. 2012 Sep;42(3):438-43 - PubMed
  8. J Cardiovasc Pharmacol. 2016 Apr;67(4):351-7 - PubMed
  9. Interact Cardiovasc Thorac Surg. 2017 May 1;24(5):783-788 - PubMed
  10. J Cardiothorac Surg. 2012 Jan 10;7:4 - PubMed
  11. Anesthesiology. 1998 Nov;89(5):1052-9 - PubMed
  12. Circulation. 2014 Dec 2;130(23):e199-267 - PubMed
  13. Circulation. 2007 Mar 20;115(11):1339-44 - PubMed
  14. Ann Pharmacother. 2014 Mar;48(3):314-9 - PubMed
  15. Am Heart J. 2000 Jul;140(1):176-80 - PubMed
  16. Chest. 1994 Jun;105(6):1642-5 - PubMed
  17. Europace. 2012 Feb;14(2):159-74 - PubMed
  18. Am J Cardiol. 2001 Aug 15;88(4):436-8 - PubMed
  19. Ann Intern Med. 1998 Aug 15;129(4):279-85 - PubMed
  20. JAMA. 2014 Aug 13;312(6):616-22 - PubMed
  21. Ann Pharmacother. 2009 Jul;43(7):1181-8 - PubMed
  22. Lancet. 2008 May 31;371(9627):1839-47 - PubMed
  23. J Emerg Med. 2015 Aug;49(2):175-82 - PubMed
  24. Eur J Cardiothorac Surg. 2007 Jan;31(1):70-4 - PubMed
  25. Ann Surg. 2016 Aug;264(2):244-51 - PubMed
  26. Eur J Cardiovasc Prev Rehabil. 2008 Dec;15(6):735-41 - PubMed
  27. J Cardiothorac Vasc Anesth. 2015 Apr;29(2):389-95 - PubMed
  28. Eur J Emerg Med. 2015 Jun;22(3):150-4 - PubMed
  29. J Am Coll Cardiol. 2003 Oct 1;42(7):1262-8 - PubMed
  30. J Am Coll Cardiol. 2004 Apr 7;43(7):1201-8 - PubMed
  31. J Biomed Res. 2014 Jan;28(1):1-17 - PubMed
  32. Chest. 2017 Jan;151(1):149-159 - PubMed
  33. J Anesth. 2013 Feb;27(1):56-61 - PubMed
  34. Int J Surg. 2006;4(2):115-7 - PubMed
  35. Ann Thorac Surg. 2017 May;103(5):1566-1572 - PubMed
  36. Circulation. 2003 Sep 9;108 Suppl 1:II195-9 - PubMed
  37. Ann Thorac Surg. 2011 Sep;92(3):1144-52 - PubMed
  38. J Thorac Cardiovasc Surg. 2004 Mar;127(3):779-86 - PubMed
  39. Br Med J. 1909 Nov 27;2(2552):1528 - PubMed
  40. J Thorac Cardiovasc Surg. 2012 Nov;144(5):1249-53 - PubMed

Publication Types